Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

28. Oktober 2010 09:00 ET | Quelle: ImmuneRegen BioSciences Inc.

ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration

SCOTTSDALE, Ariz., Oct. 28, 2010 (GLOBE NEWSWIRE) -- ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB:IRBS), today announced that treatment with...
08. September 2010 07:00 ET | Quelle: ImmuneRegen BioSciences Inc.

ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)

SCOTTSDALE, Ariz., Sept. 8, 2010 (GLOBE NEWSWIRE) -- ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB:IRBS), today announced that treatment with...
31. August 2010 14:21 ET | Quelle: ImmuneRegen BioSciences Inc.

ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for Injury Associated With Radiation Exposure

SCOTTSDALE, Ariz., Aug. 31, 2010 (GLOBE NEWSWIRE) -- ImmuneRegen BioSciences®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB:IRBS), today announced that after review of the...
25. August 2010 09:00 ET | Quelle: ImmuneRegen BioSciences Inc.

University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)

SCOTTSDALE, Ariz., Aug. 25, 2010 (GLOBE NEWSWIRE) -- ImmuneRegen BioSciences®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB:IRBS), today announced that the National Institute...